Who Pays Your Oncologist?

A recent economic analysis concluded that patients with metastatic cancer value their treatments significantly more than regulators recognize, with many expensive new therapies looking like veritable bargains to most patients…(Read the rest and view comments at Critical Decisions)

This entry was posted in Medical Decision Making and tagged , . Bookmark the permalink.

Comments are closed.